Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1343608

registered interest
date	05/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress he has made on research into the efficacy of a third booster dose of a covid-19 vaccine for immunocompromised and immunosuppressed groups.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	27084
answer	answer is ministerial correction date of answer 13/07/2021 answer text <p>The COV-BOOST study was commissioned through the National Institute for Health Research and will provide vital data on the impact of a third dose on patients’ immune responses. Initial findings are expected in September. To fully understand how COVID-19 vaccines respond as a booster dose they must first be studied in people with a fully functioning immune system.</p><p>UK Research and Innovation is providing £4 million towards the OCTAVE study examining COVID-19 vaccine responses in clinically at-risk groups, including immunocompromised patients.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/07/2021 15:40:44 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1538 label Biography information for Rosie Cooper

1316735

registered interest
date	20/05/2021
answering body	Foreign, Commonwealth and Development Office
answering dept id	208
answering dept short name	Foreign, Commonwealth and Development Office
answering dept sort name	Foreign, Commonwealth and Development Office
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what recent discussions his Department has had with AstraZeneca and Oxford University on their commitment to the WHO Covid-19 Technology Access Pool.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	4561
answer	answer is ministerial correction date of answer 28/05/2021 answer text <p>Since the World Health Organisation (WHO) provided initial details on the COVID-19 technology access pool (C-TAP) in October 2020, the UK has led the way in bringing industry and the research community to the table. During our G7 presidency, we will continue this work with stakeholders, including the WHO as it establishes the governance structures, and refines the operating model for C-TAP. This includes pharmaceutical sector representatives, and research institutions such as Oxford University.</p><p>The Foreign, Commonwealth and Development Office (FCDO) is working closely with key development partners in vaccines, such as the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi the Vaccines Alliance, WHO, and the United Nations International Children's Emergency Fund (UNICEF), along with development finance institutions, and the private sector to catalyse investments into vaccine manufacturing in Africa.</p> answering member constituency Aldridge-Brownhills answering member printed Wendy Morton question first answered 28/05/2021 10:33:31 answering member 4358 label Biography information for Wendy Morton
tabling member	1538 label Biography information for Rosie Cooper

1286541

registered interest
date	11/02/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how young people aged 16-18 in priority groups 4 or 6 are being supported to take-up the covid-19 vaccine; and what proportion of young people in those groups have been offered the vaccine.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	153169
answer	answer is ministerial correction date of answer 19/04/2021 answer text <p>The Government is committed to supporting all those offered the COVID-19 vaccine to take up this offer. Phase one of the vaccination programme includes those considered clinically extremely vulnerable in priority group four and those have underlying conditions which increase their risks from COVID-19 in priority group six. Both groups include all those who meet the clinical criteria and who are aged 16 years old and over.</p><p> </p><p>The vaccine offer was communicated directly to all those in priority groups four and six by the National Health Service. Communications for those aged 18 years old or over are directly to the individual. For those aged 16-17 years old the communication is made by agreement by either with the individual or their parents or carers. General practitioners and other clinicians involved in a young person care are available to discuss any concerns they or their parents or carers may have.</p><p> </p><p>Data is not held centrally on the number of people in priority groups four and six who have been offered the vaccine. Data is held on the number of people who have been vaccinated from these groups but is not held in the format requested.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 19/04/2021 09:16:51 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 84106 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1538 label Biography information for Rosie Cooper

1284939

registered interest
date	08/02/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 2 February 2020 to Question 124263, on Coronavirus: Vaccination, what dataset his Department is using to identify unpaid carers in order to offer them a covid-19 vaccination.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	150727
answer	answer is ministerial correction date of answer 07/04/2021 answer text <p>The Standard Operating Procedure (SOP) for unpaid carers was published on 8 March. It outlines the numbers of existing sources that will be drawn from to identify unpaid carers. They are:</p><p>- those in receipt of or entitled to a carer’s allowance;</p><p>- those known to GPs who have a ‘carer’s flag’ on their primary care record;</p><p>- those known to Local Authorities who are in receipt of support following a carer’s assessment; and</p><p>- those known to local carers organisations to be actively receiving care and support.</p><p> </p><p>The SOP is available at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/coronavirus/publication/sop-covid-19-vaccine-deployment-programme-unpaid-carers-jcvi-priority-cohort-6/" target="_blank">https://www.england.nhs.uk/coronavirus/publication/sop-covid-19-vaccine-deployment-programme-unpaid-carers-jcvi-priority-cohort-6/</a></p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 07/04/2021 09:28:35 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 82404 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1538 label Biography information for Rosie Cooper

1284940

registered interest
date	08/02/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if the Government will publish information on the effectiveness of each type of covid-19 vaccine on (a) immuno-suppressed and (b) other clinically vulnerable people to encourage people in those groups to take up those vaccines.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	150728
answer	answer is ministerial correction date of answer 15/02/2021 answer text <p>Public Health England is monitoring the effectiveness and impact of COVID-19 vaccines on a broad range of outcomes including symptomatic disease, infection and hospitalisations as set out in the COVID-19 vaccine surveillance strategy which is available at the following link:</p><p> </p><p><a href="https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fpublications%2Fcovid-19-vaccine-surveillance-strategy&amp;data=04%7C01%7CParliamentary%40phe.gov.uk%7C7dc5b2e7dcf841c208ab08d8cd22be7f%7Cee4e14994a354b2ead475f3cf9de8666%7C0%7C0%7C637484896395869602%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=xF%2FF1XBj1dSfVyLXyeuSYASX7Ct%2B5dZ5LtB8jRtg4%2FY%3D&amp;reserved=0" target="_blank">https://www.gov.uk/government/publications/covid-19-vaccine-surveillance-strategy</a></p><p> </p><p>Vaccine effectiveness assessments are reported regularly to the Joint Committee on Vaccination and Immunisation (JCVI) to inform vaccine policy recommendations. This will include assessment of vaccine effectiveness in immunocompromised individuals and the clinically vulnerable using general practice electronic health record data. Vaccine effectiveness data will be published in due course.</p><p> </p><p>Once sufficient evidence becomes available, the JCVI will consider options for a protection strategy for immunosuppressed individuals, including whether any specific vaccine is preferred in this population.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 15/02/2021 17:20:46 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 82342 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1538 label Biography information for Rosie Cooper

1284130

registered interest
date	04/02/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he is taking steps to asses the effect of delaying the second Pfizer/Biontech vaccine dose on immunity levels in elderly people against the South African variant of covid-19.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	149182
answer	answer is ministerial correction date of answer 15/02/2021 answer text <p>Industry led studies are ongoing to understand the level of protection the Pfizer and AstraZeneca vaccines will provide against variant strains of COVID-19. This will include immunological studies to understand the potential for protection from COVID-19 vaccines against variants and follow up of phase three trial participants in geographical areas where variants are circulating. Global surveillance systems, including systems within Public Health England, will be able to provide observational data on vaccine effectiveness against COVID-19 variants. These will be reviewed by the Joint Committee on Vaccination and Immunisation as they become available.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 149183 question first answered 15/02/2021 17:28:26 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 81562 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1538 label Biography information for Rosie Cooper

1284131

registered interest
date	04/02/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of whether elderly people will potentially have an increased risk of contracting the South African variant of covid-19 due to delaying the second dose of the Pfizer/Biontech vaccine to 12 weeks.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	149183
answer	answer is ministerial correction date of answer 15/02/2021 answer text <p>Industry led studies are ongoing to understand the level of protection the Pfizer and AstraZeneca vaccines will provide against variant strains of COVID-19. This will include immunological studies to understand the potential for protection from COVID-19 vaccines against variants and follow up of phase three trial participants in geographical areas where variants are circulating. Global surveillance systems, including systems within Public Health England, will be able to provide observational data on vaccine effectiveness against COVID-19 variants. These will be reviewed by the Joint Committee on Vaccination and Immunisation as they become available.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 149182 question first answered 15/02/2021 17:28:26 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 81551 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1538 label Biography information for Rosie Cooper

1282413

registered interest
date	01/02/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the vaccination of maritime workers by Singapore, what discussions he has had with Cabinet colleagues on prioritising maritime workers for covid-19 vaccination.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	146825
answer	answer is ministerial correction date of answer 16/02/2021 answer text <p>The Secretary of State for Health and Social Care has had a number of discussions with Cabinet colleagues on prioritisation for COVID-19 vaccination.</p><p> </p><p>The Joint Committee on Vaccination and Immunisation (JCVI) are the independent experts who advise the Government on which vaccine/s the United Kingdom should use and provide advice on who should be offered the vaccination first. The key principles are to reduce mortality, to protect the health and care systems and save lives. For the first phase, the JCVI has advised that the vaccine be given to care home residents and staff, as well as frontline health and social care workers, then to the rest of the population in order of age and clinical risk factors.</p><p> </p><p>Prioritisation decisions for the next phase are subject to surveillance and monitoring data and information from phase one, as well as further input from independent scientific experts such as the JCVI. Phase two may include further reduction in hospitalisation and targeted vaccination of those at high risk of exposure and/or those delivering key public services.</p><p> </p><p> </p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 16/02/2021 09:59:33 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 80342 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1538 label Biography information for Rosie Cooper

1279689

registered interest
date	22/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that people without access to a (a) telephone or (b) computer can receive notice of their covid-19 vaccination appointment in a timely manner.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	141950
answer	answer is ministerial correction date of answer 01/04/2021 answer text <p>The National Booking Service is sending physical invitation letters to registered addresses. Others can make an appointment on behalf of individuals who are not able to make it themselves.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 01/04/2021 12:26:14 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1538 label Biography information for Rosie Cooper

1273278

registered interest
date	30/12/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of including dental professionals on the list of people eligible for early covid-19 vaccination.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	132825
answer	answer is ministerial correction date of answer 11/01/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) consists of independent experts who advise the Government on which vaccine/s the United Kingdom should use, including prioritisation at a population level. For the first phase, the JVCI has advised that the vaccine be given to care home residents and staff, as well as frontline health and social care workers, then to the rest of the population in order of age and clinical risk factors. Included are those with underlying health conditions, which put them at higher risk of serious disease and mortality.</p><p> </p><p>Frontline healthcare staff include those who have frequent face-to-face clinical contact with patients and who are directly involved in patient care in either secondary or primary care/community settings. This includes dentists, as well as non-clinical ancillary staff who may have social contact with patients but are not directly involved in patient care. Their advice states that this not only includes those working for the National Health Service, but also those in independent, voluntary, non-standard and community healthcare settings.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 11/01/2021 16:55:38 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1538 label Biography information for Rosie Cooper